论文部分内容阅读
目前,临床上多数中晚期食管癌应用以放疗为主的综合治疗,患者症状有所缓解、生活质量得以提高,但总的生存率并不高;治疗失败的主要原因是局部复发和远处转移。为探讨同期放化疗治疗中晚期食管癌的价值,1999~2002年我科对收治的76例中晚期食管癌患者,分为采取同期放化疗及单纯放
Currently, the majority of clinical application of advanced esophageal cancer to radiotherapy-based comprehensive treatment of patients with symptoms eased, quality of life can be improved, but the overall survival rate is not high; the main reason for treatment failure is local recurrence and distant metastasis . In order to explore the value of radiotherapy and chemotherapy in the treatment of advanced esophageal cancer in the same period, from 1999 to 2002, 76 cases of advanced esophageal cancer admitted to our department were divided into two groups: